Cystic Fibrosis: all 1,605 studies
Page 15 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Antibiotics for Pseudomonas in Early CFCompletedNCT00823238Phase 1
- Airway Clearance Using High Frequency Chest Wall OscillationCompletedNCT00817947Phase 3
- Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic FibrosisCompletedNCT00817180Phase 2
- Study to Assess Efficacy of AZD1236 in Patients With Cystic FibrosisWithdrawnNCT00812045Phase 2
- Do Physiotherapy Techniques Improve Posture During Admission for a Chest Infection in Adults With Cystic Fibrosis?CompletedNCT00806884Not applicable
- Exercise-Induced Bronchospasm in Cystic FibrosisCompletedNCT00806455
- Sleep in Patients With Cystic FibrosisCompletedNCT00804661
- Genetic Modifiers of Cystic Fibrosis (CF) Liver DiseaseActive, not recruitingNCT00804583
- Longitudinal Pathogen-colonization in Cystic Fibrosis Airways and Ability to SmellStatus unknownNCT00803881
- Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCompletedNCT00800579Phase 1
- Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung InfectionCompletedNCT00794586Phase 2
- Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis PatientsCompletedNCT00792714Phase 1
- Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training PeriodCompletedNCT00792194Not applicable
- Cystic Fibrosis Foundation (CFF) Biomarkers of ExacerbationCompletedNCT00788359
- Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic FibrosisCompletedNCT00788138Not applicable
- Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic TherapyCompletedNCT00786513Phase 2
- Cystic Fibrosis (CF) Flow Rates StudyCompletedNCT00779077
- Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa ColonizationCompletedNCT00774072Phase 2
- An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis PatientsWithdrawnNCT00765401
- Ghrelin in Cystic FibrosisStatus unknownNCT00763477Not applicable
- Vitamin D3 for the Treatment of Low Vitamin D in Cystic FibrosisWithdrawnNCT00762918Phase 3
- Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)CompletedNCT00760071
- Cystic Fibrosis Core Strengthening and Respiratory Exercise ProgramCompletedNCT00751647Phase 2
- Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic FibrosisCompletedNCT00750932
- A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast DiseaseCompletedNCT00744276Phase 2
- Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo ControlTerminatedNCT00744250Phase 4
- Transfer Impedance in Cystic FibrosisWithdrawnNCT00743158
- Miglustat in Cystic FibrosisCompletedNCT00742092Phase 2
- Effects of 5-Methyltetrahydrofolate and Vitamin B12 Supplemetation on Red Cell Membrane in Children With Cystic FibrosisCompletedNCT00730509Not applicable
- Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel TherapiesCompletedNCT00727285
- Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic FibrosisCompletedNCT00721071Phase 2
- Effect of Pioglitazone on Inflammation in Cystic FibrosisCompletedNCT00719381Phase 1
- Do Musculoskeletal Techniques Improve Forced Expiratory Volume in One Second in Adults With Cystic Fibrosis?CompletedNCT00716664Not applicable
- Infant Study of Inhaled Saline in Cystic FibrosisCompletedNCT00709280Not applicable
- Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis AirwaysCompletedNCT00700050
- Changes in Adherence After Playing "My Life With CF" GameCompletedNCT00688051Not applicable
- Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical DecayStatus unknownNCT00687466Phase 3
- Choline Nutrition in Children With Cystic Fibrosis (CF)CompletedNCT00686361Not applicable
- Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) PatientsCompletedNCT00685971Not applicable
- 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis PatientsCompletedNCT00684346Phase 3
- The EPIC Observational StudyCompletedNCT00676169
- Lancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic FibrosisCompletedNCT00671736Phase 2
- Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)CompletedNCT00670579
- Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis PatientsCompletedNCT00669760
- Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) PatientsWithdrawnNCT00663975Not applicable
- Early Diagnosis of Diabetes Mellitus in Patients With Cystic FibrosisCompletedNCT00662714Phase 3
- The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic FibrosisCompletedNCT00635141Phase 3
- Anti-pseudomonas IgY to Prevent Infections in Cystic FibrosisCompletedNCT00633191Phase 1/2
- Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00625612Phase 3
- Exercise Training Study for Patients With Cystic FibrosisCompletedNCT00609050Not applicable
- SD Cystic Fibrosis StudyCompletedNCT00605761Phase 1
- Investigating Mucinase Activity in Airway DiseaseCompletedNCT00596232
- Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling PairsCompletedNCT00590330
- Nasal Potential Difference (NPD) for the Diagnosis of Cystic FibrosisCompletedNCT00589745Not applicable
- Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPACompletedNCT00585364
- Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic FibrosisTerminatedNCT00577499
- Coping Compliance and Adjustment in Adolescents With Cystic FibrosisCompletedNCT00577252
- Malabsorption Blood Test:Toward a Novel Approach to Quantify SteatorrheaCompletedNCT00572975Phase 4
- IGF-1 Therapy in Patients With Cystic FibrosisTerminatedNCT00566241Phase 1
- NPD Measurement in InfantsStatus unknownNCT00564304
- The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic FibrosisCompletedNCT00557089Phase 4
- Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic FibrosisCompletedNCT00547053Phase 1
- Tissue Bank for Pulmonary DiseasesCompletedNCT00546962
- Tolerability of Inhaled Hypertonic Saline in Infants With Cystic FibrosisCompletedNCT00546663Not applicable
- Miglustat / OGT 918 in the Treatment of Cystic FibrosisTerminatedNCT00537602Phase 2
- Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic RhinosinusitisCompletedNCT00534079Phase 3
- Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic FibrosisCompletedNCT00531531
- Use of Formula Fortified With DHA in Infants With Cystic FibrosisCompletedNCT00530244Not applicable
- Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and PlaceboCompletedNCT00515229Phase 2
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QAU145 in Patients With Cystic FibrosisCompletedNCT00506792Phase 2
- Efficacy and Safety Study of Inhaled Glutathione in Cystic Fibrosis PatientsCompletedNCT00506688Phase 2
- Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)CompletedNCT00504361
- Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic FibrosisCompletedNCT00503490Phase 1
- Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis PatientsCompletedNCT00499837Phase 2
- Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway InfectionApproved for marketingNCT00499720
- Disclosing a Cystic Fibrosis Diagnosis to a Dating PartnerCompletedNCT00485082
- One Year Glargine Treatment in CFRD Children and AdolescentsCompletedNCT00483769Phase 4
- Nutritional, Metabolic and Respiratory Status in Cystic FibrosisCompletedNCT00476281Not applicable
- Pharmacokinetic Study of Lansoprazole in Cystic FibrosisCompletedNCT00458614Phase 1
- A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic FibrosisCompletedNCT00455130Phase 2
- Open-Label Phase III Long-Term Safety Trial of LiprotamaseCompletedNCT00449904Phase 3
- Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic InsufficiencyCompletedNCT00449878Phase 3
- Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy StudyCompletedNCT00446680Phase 3
- Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic FibrosisCompletedNCT00432861Phase 3
- Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung DiseaseTerminatedNCT00425165Phase 2
- Tobramycin Administered by eFlow Rapid Nebulizer: Pharmacokinetic StudyCompletedNCT00420836Phase 1
- Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis PeopleTerminatedNCT00418470Phase 4
- Non-Invasive Biomarkers in Cystic FibrosisCompletedNCT00413140
- Scandinavian Cystic Fibrosis Azithromycin StudyCompletedNCT00411736Phase 4
- Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PICompletedNCT00406536Phase 2
- The Short Term Safety and Efficacy of Inhaled L-arginine in Patients With Cystic FibrosisCompletedNCT00405665Phase 2
- FLAME: Airway Inflammation Monitoring in Asthma and Cystic FibrosisCompletedNCT00404859
- Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy StudyCompletedNCT00399945Phase 1
- Assessment of Quadriceps Muscle Electrostimulation Used in Patients Suffering From Cystic FibrosisTerminatedNCT00391703Not applicable
- Whole Body Vibration - a New Therapeutic Approach to Improve Muscle Function in CFCompletedNCT00388466Not applicable
- Interest of Gentamicin-induced Readthrough in Cystic Fibrosis PatientsTerminatedNCT00376428Phase 2
- Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung DiseaseCompletedNCT00368446
- 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)CompletedNCT00363402Not applicable
- Blood Collection From Individuals With Lung Disease for Genetic StudiesCompletedNCT00362739
- Antimicrobial Resistance in Cystic Fibrosis (CF)CompletedNCT00360503